Evelyne Doudnikoff
Ingénieur/technicien
IE / CNRS/ Équipe
None
/ Contact
+33 5 33 51 47 96
www.orcid.org/0000-0002-3770-8585
/ Adresse
IMN - UMR 5293 - CNRS/Université de Bordeaux - Centre Broca Nouvelle-Aquitaine – 3e étage - 146 rue Léo-Saignat- CS 61292 – Case 28 - 33076 Bordeaux cedex - France
Publications
-
A population of Insula neurons encodes for social preference only after acute social isolation in mice
Nat Commun. 2024-08-21. 15(1)
10.1038/s41467-024-51389-4 -
Encoding social preference by interhemispheric neurons in the Insula
. 2022-12-15.
10.1101/2022.12.15.520538 -
The Zinc Ionophore Clioquinol Reduces Parkinson’s Disease Patient-Derived Brain Extracts-Induced Neurodegeneration
Mol Neurobiol. 2022-08-02.
10.1007/s12035-022-02974-5 -
Acidic nanoparticles protect against α-synuclein-induced neurodegeneration through the restoration of lysosomal function.
Aging cell. .
10.1111/acel.13584 -
Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism
Brain. 2022-03-04.
10.1093/brain/awac087 -
Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy
Cells. 2020-10-29. 9(11) : 2371.
10.3390/cells9112371 -
Novel self-replicating α-synuclein polymorphs that escape ThT monitoring can spontaneously emerge and acutely spread in neurons
Sci. Adv.. 2020-10-01. 6(40) : eabc4364.
10.1126/sciadv.abc4364 -
Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling
Nat Commun. 2020-07-10. 11(1)
10.1038/s41467-020-17328-9 -
Emergence of stealth polymorphs that escape α-synuclein amyloid monitoring, take over and acutely spread in neurons
. 2020-02-12.
10.1101/2020.02.11.943670 -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in non-human primates
. 2019-10-31.
10.1101/825216 -
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies
JCI Insight. 2019-08-22. 4(16)
10.1172/jci.insight.129719 -
Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia
Sci Rep. 2017-05-24. 7(1)
10.1038/s41598-017-02572-9 -
CD154 Induces Matrix Metalloproteinase-9 Secretion in Human Podocytes.
J. Cell. Biochem.. 2016-05-05. 117(12) : 2737-2747.
10.1002/jcb.25571 -
Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
Biological Psychiatry. 2016-03-01. 79(5) : 354-361.
10.1016/j.biopsych.2014.07.007 -
Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
Biological Psychiatry. 2016-03-01. 79(5) : 345-353.
10.1016/j.biopsych.2014.08.022 -
D1 dopamine receptor stimulation impairs striatal proteasome activity in Parkinsonism through 26S proteasome disassembly.
Neurobiology of Disease. 2015-06-01. 78 : 77-87.
10.1016/j.nbd.2015.02.024 -
Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?
Front. Aging Neurosci.. 2014-09-24. 6
10.3389/fnagi.2014.00258 -
Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors.
Proceedings of the National Academy of Sciences. 2013-10-14. 110(44) : 18005-18010.
10.1073/pnas.1310145110 -
D1 dopamine receptor-mediated LTP at GABA synapses encodes motivation to self-administer cocaine in rats.
Journal of Neuroscience. 2013-07-17. 33(29) : 11960-11971.
10.1523/jneurosci.1784-13.2013 -
Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration.
Proceedings of the National Academy of Sciences. 2012-05-30. 109(24) : 9611-9616.
10.1073/pnas.1112368109 -
Endogenous morphine-like compound immunoreactivity increases in parkinsonism.
Brain. 2011-07-08. 134(8) : 2321-2338.
10.1093/brain/awr166 -
Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson’s disease.
Science Translational Medicine. 2010-04-21. 2(28) : 28ra28-28ra28.
10.1126/scitranslmed.3000664 -
Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.
Journal of Neuroscience. 2009-04-15. 29(15) : 4829-4835.
10.1523/jneurosci.5884-08.2009 -
Antagonizing L-type Ca2+ channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia.
Biological Psychiatry. 2009-03-01. 65(6) : 518-526.
10.1016/j.biopsych.2008.09.008 -
Striatal proteomic analysis suggests that first L-dopa dose equates to chronic exposure.
PLoS ONE. 2008-02-13. 3(2) : e1589.
10.1371/journal.pone.0001589 -
Cytoplasmic expression of human telomerase catalytic protein (hTERT) in neutrophils: an immunoelectron microscopy study.
Ultrastructural Pathology. 2008-01-01. 32(5) : 178-183.
10.1080/01913120802034504 -
Differences in ultrastructural localization of dopaminergic D1 receptors between dorsal striatum and nucleus accumbens in the rat.
Neuroscience Letters. 2007-06-01. 419(3) : 273-277.
10.1016/j.neulet.2007.04.034 -
Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
Neurobiology of Disease. 2007-05-01. 26(2) : 452-463.
10.1016/j.nbd.2007.02.001 -
Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
The International Journal of Biochemistry & Cell Biology. 2005-09-23.
10.1016/j.biocel.2005.08.021 -
Aging and subcellular localization of m2 muscarinic autoreceptor in basalocortical neurons in vivo.
Neurobiology of Aging. 2005-07-01. 26(7) : 1061-1072.
10.1016/j.neurobiolaging.2004.09.007